Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vaginal Fluorouracil Maintenance for Cervical Dysplasia in HIV-Infected Women
NCT00000758Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in cervical dysplasia (CIN) comparing Fluorouracil with Observation (2 arms). Primary endpoint: Recurrence of cervical dysplasia at 6 months. Status: completed.
02
Drugs
fluorouracil
03
Conditions
cervical dysplasia (CIN)
Beyond the preview
Go deeper on NCT00000758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000758.